P1228 COMPARATIVE RESISTANCE ANALYSIS BETWEEN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT EXPERIENCED PATIENTS WHO FAILED TREATMENT WITH A COMBINATION OF VANIPREVIR (MK-7009) AND PEGYLAT... von Ludmerer, S, Barnard, R, Brunhoffer, J, Howe, A, Hwang, P.M.T, Liu, R, Zhou, A, Mobashery, N

Volltext

1198 RESISTANCE ANALYSIS OF CIRRHOTIC TREATMENT-EXPERIENCED GENOTYPE 1 PATIENTS IN A STUDY OF MK-7009 IN COMBINATION WITH PEGYLATED INTERFERON/RIBAVIRIN von Barnard, R, Hwang, P.M.T, Bhanja, S, Campbell, H, Strizki, J, Cheney, C, McHale, C, Newhard, W, Hazuda, D, Mobashery, N, Howe, A

Volltext

803 RELATIONSHIP BETWEEN TRANSAMINASE LEVELS AND PLASMA PHARMACOKINETICS FOLLOWING ADMINISTRATION OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) TO HCV GENOTYPE (G... von Caro, L, Du, L, Huang, S, Wenning, L, Su, J, Hwang, P.M.T, Valesky, R, Gilbert, C, Gress, J, Klaassen, F, Gendrano, I.N, Brunhofer, J, Cooreman, M, Huisman, J, Mobashery, N

Volltext

Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (Pts) with gastric or gastroesophagea... von Bang, Y.-J., Van Cutsem, E., Fuchs, C.S., Ohtsu, A., Tabernero, J., Ilson, D.H., Hyung, W.J., Strong, V.E., Goetze, T.O., Yoshikawa, T., Tang, L.H., Hwang, P.M.T., Adelberg, D., Shitara, K.

Volltext

Phase III KEYNOTE-585 study of chemotherapy (Chemo) plus pembrolizumab (Pembro) vs chemo plus placebo as neoadjuvant/adjuvant treatment for patients (Pts) with gastric or gastroeso... von Bang, Y.-J, Van Cutsem, E, Fuchs, C.S, Ohtsu, A, Tabernero, J, Ilson, D.H, Hyung, W.J, Strong, V.E, Goetze, T.O, Yoshikawa, T, Tang, L.H, Hwang, P.M.T, Adelberg, D, Shitara, K

Volltext